Vitamin D3 for Life

Live Enlightened

Article

25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Physiological Meaning and Regulation: Study Summary

Previous related page25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Physiological Meaning and Regulation: Full StudyNext related pageBone Mineralisation, Turnover and Fractures Measure Different Outcomes
Study at a glance

Why can the usual vitamin D test and the active vitamin D test give different results?

This page asks why two vitamin D blood tests can give different results. The usual test measures 25-hydroxyvitamin D, the main form available for conversion into active vitamin D. Another test measures 1,25-dihydroxyvitamin D, the active hormone. Kidney function and other hormones help control the active form.

Who was studied to compare the two vitamin D blood tests?

The page combines research reviews with a study of patient records. Researchers examined 319 patients with low 25-hydroxyvitamin D and compared groups with different levels. They measured active vitamin D, calcium absorption and parathyroid hormone, which helps control calcium.

How did active vitamin D levels change when the usual vitamin D test was low?

Active vitamin D and calcium absorption were maintained across much of the low-vitamin-D range while parathyroid hormone rose. The hormone can help the kidneys make more active vitamin D. In the group with 25-hydroxyvitamin D at 10 nmol/L or below, active vitamin D and calcium absorption fell. The body’s ability to maintain active vitamin D was therefore limited.

Can active vitamin D stay normal when the usual blood test shows low vitamin D?

Normal active vitamin D does not rule out low 25-hydroxyvitamin D. Low active vitamin D can also reflect kidney or hormone problems, rather than low vitamin D intake alone. The patient study looked back at records from a particular group of patients. Its 10 nmol/L finding does not set a treatment threshold for everyone, and neither blood test measures all vitamin D effects in tissues.

Read the full article below ↓

25-hydroxyvitamin D and 1,25-dihydroxyvitamin D are related metabolites, but they are not interchangeable blood markers. 25(OH)D mainly reflects the circulating vitamin D substrate pool and is the standard marker used when vitamin D status is being assessed. 1,25(OH)₂D is the active endocrine hormone and is regulated tightly by the kidney, PTH, FGF23 and feedback.

What question did this evidence investigate?

The evidence asks why the two metabolites can give apparently different messages and what each concentration actually represents. The key issue is whether active-hormone concentration simply tracks vitamin D stores, or whether homeostatic regulation can separate the two.

What was studied?

The evidence combines clinical laboratory reviews, mechanistic reviews of renal regulation, and a primary clinical study by Need and colleagues. In that study, 319 patients with 25(OH)D at or below 40 nmol/L were identified from 3,661 patient records and grouped by the severity of low 25(OH)D.

What did the researchers find?

Across much of the low-25(OH)D range, serum 1,25(OH)₂D and calcium absorption were maintained while PTH rose. This supports a homeostatic explanation: increased PTH can stimulate renal activation and defend active hormone even while the 25(OH)D substrate pool is reduced. In the most severely depleted group, at 10 nmol/L 25(OH)D or below, 1,25(OH)₂D and calcium absorption fell, showing that compensation is not unlimited.

Mechanistic evidence explains the wider pattern. Renal CYP27B1 is stimulated by PTH and restrained by FGF23 and feedback from 1,25(OH)₂D, while CYP24A1 contributes to degradation. By contrast, hepatic production of 25(OH)D is less tightly regulated and more closely reflects substrate availability.

What does this evidence support?

It supports using 25(OH)D, rather than 1,25(OH)₂D, as the ordinary marker of vitamin D status when status testing is clinically indicated. It also supports the apparently counterintuitive possibility that someone can have low 25(OH)D while circulating active hormone remains normal. A normal 1,25(OH)₂D result therefore does not establish adequate vitamin D status.

What does this evidence not establish?

It does not show that 1,25(OH)₂D is always normal or high in deficiency. Severe substrate depletion, impaired renal activation and altered mineral-endocrine regulation can lower it. It also does not show that 25(OH)D measures tissue-level vitamin D effect. Local activation and receptor responses are not captured fully by either circulating number.

Why a normal active-hormone result can be misleading

The active hormone is not a passive downstream reflection of the 25(OH)D pool. PTH can increase conversion when mineral physiology demands it, while FGF23 and feedback can restrain production. This means the body can preserve the active-hormone concentration by changing regulatory effort. A normal 1,25(OH)₂D result can therefore coexist with a low status marker and should not be used to rule out low 25(OH)D.

The reverse also matters. Low 1,25(OH)₂D can arise when renal activation is impaired or when endocrine regulation is altered. It is not automatically evidence of nutritional vitamin D deficiency. The metabolite has to be interpreted as a regulated hormone rather than as a second version of the same status test.

Why kidney regulation matters

The kidney is the main source of circulating 1,25(OH)₂D, so renal function and mineral hormones can alter the active-hormone result independently of vitamin D supply. This is why Vitamin D and Kidneys is relevant when the two biomarkers appear discordant.

What are the main limitations?

The primary severe-deficiency study was retrospective and came from a clinical referral population, so its approximate 10 nmol/L transition should not be turned into a universal treatment threshold. Its value is physiological: it demonstrates that compensation can preserve active hormone across substantial substrate depletion and that this compensation can eventually fail. The broader regulatory interpretation is strengthened by mechanistic and clinical laboratory reviews rather than resting on that one dataset alone.

Assay method also matters. 25(OH)D and especially 1,25(OH)₂D can be affected by analytical limitations, so an unexpected result needs to be interpreted with the method and clinical context in mind rather than treated as a pure readout of biology.

Why this matters within vitamin D physiology

The practical distinction is between a status/substrate marker and a regulated hormone. Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D provides the wider testing framework, while Free vs Total Vitamin D Explained addresses another measurement distinction involving binding and circulating fractions.

For the deeper evidence review, see 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Physiological Meaning and Regulation: Full Study.

Primary evidence and source details

Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency. Need AG et al. Journal of Bone and Mineral Research. 2008;23:1859 to 1863.

The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine. Dirks NF et al. Nutrients. 2018;10:482.

Vitamin D Assays. Bikle DD. Frontiers of Hormone Research. 2018;50:14 to 30.

Related reading

Original sources

Source

Vitamin D Assays

Published in Bikle DD. Frontiers of Hormone Research (2018).

Publication details

Vitamin D Assays. Bikle DD. Frontiers of Hormone Research. 2018;50:14 to 30.

Read more →